Related Experiment Video
Updated: Jul 31, 2026
08:34
Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
Published on: June 3, 2016
beta-cell function in obesity: effects of weight loss
Ele Ferrannini1, Stefania Camastra, Amalia Gastaldelli
1Department of Internal Medicine, Via Savi, 8, 56126 Pisa, Italy. ferranni@ifc.cnr.it
Diabetes
|November 25, 2004
Summary
Obesity increases beta-cell mass and insulin secretion, independent of insulin resistance. Weight loss reduces insulin hypersecretion, but malabsorptive surgery normalizes it, suggesting gastrointestinal factors are key.
Area of Science:
- Endocrinology
- Metabolic Research
- Obesity Studies
Background:
- Obesity is linked to increased beta-cell mass (10-30% per 10kg excess weight).
- The impact of obesity's duration, onset, weight changes, and fat distribution on beta-cell mass is unclear.
- Fasting and glucose-stimulated insulin secretion increase linearly with BMI, correlating with fat-free and fat mass.
Purpose of the Study:
- To investigate the relationship between obesity and beta-cell function in nondiabetic individuals.
- To explore the effects of obesity duration, weight changes, and body fat distribution on beta-cell mass.
- To understand the impact of weight loss and different bariatric surgery types on insulin secretion and resistance.
Main Methods:
- Analysis of insulin secretion (fasting and oral glucose tolerance tests) in relation to Body Mass Index (BMI), fat-free mass, and fat mass.
- Assessment of dynamic beta-cell function (glucose sensitivity, rate sensitivity, potentiation) in obese and non-obese states.
- Evaluation of changes in insulin sensitivity and secretion following dietary weight loss and various bariatric surgical procedures (restrictive vs. malabsorptive).
Main Results:
- Insulin secretion increases with BMI, independent of insulin resistance, suggesting primary hypersecretion in obesity.
- Dynamic beta-cell functions remain largely unaffected by obesity, fat distribution, or insulin resistance if glucose tolerance is maintained.
- Weight loss reduces insulin resistance and hypersecretion, though hypersecretion may persist.
- Malabsorptive bariatric surgery normalizes insulin sensitivity and abolishes hypersecretion, even before significant weight loss.
Conclusions:
- Obesity is characterized by increased beta-cell mass and insulin hypersecretion, potentially driven by factors beyond insulin resistance.
- While weight loss mitigates some effects, malabsorptive surgery offers a more profound normalization of metabolic parameters.
- Gastrointestinal lipid signaling pathways are implicated as potential mediators in obesity-related metabolic changes and warrant further investigation.
Related Concept Videos
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
01:16Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.